MST1 downregulates TAZ tumor suppressor protein in multiple myeloma and is a potential therapeutic targetSamuel O. Abegunde(University of New Brunswick), Tony Reiman(University of New Brunswick)Experimental HematologyMay 1, 202310.1016/j.exphem.2023.04.004Cited by 6SaveCiteExport RISWatch citationsRelated PapersInternational Myeloma Working Group molecular classification of multiple myeloma: spotlight review|Leukemia|2009|877TAZ functions as a tumor suppressor in multiple myeloma by downregulating MYC|Blood Advances|2019|36